Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Go back to Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
StemCells, Inc. (NASDAQ: TEM) Delayed: 64.29 -0.33 (0.51%)
Previous Close $64.62    52 Week High $0.45 
Open $64.04    52 Week Low $0.37 
Day High $65.79    P/E N/A 
Day Low $63.21    EPS $-0.31 
Volume 5,193,709